Appetite, Glycemia and Entero-Insular Hormone Responses Differ Between Oral, Gastric-Remnant and Duodenal Administration of a Mixed Meal Test After

Similar documents
Management of Type 2 Diabetes

New and Emerging Therapies for Type 2 DM

type 2 diabetes is a surgical disease

Technique. Matthew Bettendorf, MD Essentia Health Duluth Clinic. Laparoscopic approach One 12mm port, Four 5mm ports

Roux-and-Y Gastric Bypass and its Metabolic Effects

Bariatric Surgery MM /11/2001. HMO; PPO; QUEST 05/01/2012 Section: Surgery Place(s) of Service: Outpatient; Inpatient

Megan Lawless. Journal Club. January 20 th, 2011

New Insights into Mechanism of Action

Disclosure. Learning Objectives. Case. Diabetes Update: Incretin Agents in Diabetes-When to Use Them? I have no disclosures to declare

Chief of Endocrinology East Orange General Hospital

What is Metabolic About Metabolic Surgery? The New ADA Recommendations

Gastric Emptying Time after Laparoscopic Sleeve Gastrectomy

Effect of macronutrients and mixed meals on incretin hormone secretion and islet cell function

Appetite control, obesity & bariatric surgery

New insights in metabolic surgery

Type 2 diabetes and metabolic surgery:

Understanding the Effects of Roux-en-Y Gastric Bypass (RYGB) Surgery on Type 2 Diabetes Mellitus

GLP-1 agonists. Ian Gallen Consultant Community Diabetologist Royal Berkshire Hospital Reading UK

Commonly Performed Bariatric Procedures in Singapore. Lin Jinlin Associate Consultant General, Upper GI and Bariatric Surgery Changi General Hospital

Bariatric Procedures and Mechanisms of Weight Loss. September 22 nd, 2018 Aryan Modasi MD MSc FRCSC

BARIATRIC SURGERY AND TYPE 2 DIABETES MELLITUS

Pathogenesis of Type 2 Diabetes

Treating Type 2 Diabetes with Bariatric Surgery. Goal of Treating T2DM. Remission of T2DM with Bariatric

New Treatments for Type 2 diabetes. Nandini Seevaratnam April 2016 Rushcliffe Patient Forum

INJECTABLE THERAPY FOR THE TREATMENT OF DIABETES

Bariatric Surgery MM /11/2001. HMO; PPO; QUEST Integration 04/28/2017 Section: Surgery Place(s) of Service: Outpatient; Inpatient

Benefits of Bariatric Surgery

INJECTABLE THERAPIES IN DIABETES. Barbara Ann McKee Diabetes Specialist Nurse

Practical Strategies for the Clinical Use of Incretin Mimetics CME/CE. CME/CE Released: 09/15/2009; Valid for credit through 09/15/2010

SLENDESTA POTATO EXTRACT PROMOTES SATIETY IN HEALTHY HUMAN SUBJECTS: IOWA STATE UNIVERSITY STUDY Sheila Dana, Michael Louie, Ph.D. and Jiang Hu, Ph.D.

Current Status of Bariatric Surgery in Asia

Dianne Kristine Joy Closa*, Armin Masbang, Dianne Shari Cabrera, Allan Dampil and Robert Mirasol

Gut hormones KHATTAB

Objectives. Define satiety and satiation Summarize the satiety cascade Describe potential dietary interventions aimed at improving satiety

Management of diabetes with Bariatric surgery. Muhammad Jawad MD FACS FASMBS

Viriato Fiallo, MD Ursula McMillian, MD

The Bariatric and Heartburn Center of Northeast Ohio

22 Emerging Therapies for

Obesity Management Workshop for Health Professionals

la prise en charge du diabète de

Update on GLP-1 Past Present Future

Type 2 diabetes and metabolic surgery:

Bariatric surgery: Impact on Co-morbidities and Weight Loss Expectations ALIYAH KANJI, MD FRCSC MIS AND BARIATRIC SURGERY SEPTEMBER 22, 2018

Diabetes Meds Update Disclaimer and Important Info. Objectives. Page 1. Copyright , Diabetes Education Services

Preserved insulin secretory capacity and weight loss are the predominant predictors

Postgastrectomy Syndromes

Sweetness and Glycaemic Regulation. (A focus on gut related and physiological aspects) John McLaughlin Manchester University

Endoscopic Duodenal Jejunal Bypass Liner Rapidly Improves Type 2 Diabetes

Professor Rudy Bilous James Cook University Hospital

Metabolic and Hormonal Changes After Laparoscopic Roux-en-Y Gastric Bypass and Sleeve Gastrectomy: a Randomized, Prospective Trial

Gastric By-Pass and Remission of Type II Diabetes in Obese Adults

Neuroprotective properties of GLP-1 - a brief overview. Michael Gejl Jensen, MD Dept. Of Pharmacology, AU

OBESITY AND WEIGHT LOSS SURGERY FOR THE PRIMARY CARE PHYSICIAN

Christine Pelkman, PhD

Diabetes Care Publish Ahead of Print, published online November 16, 2009

Comparison Between Laparoscopic Sleeve Gastrectomy and Laparoscopic Adjustable Gastric Banding for Morbid Obesity: a Meta-analysis

Obesity and Weight Loss Surgery for the Primary Care Physician

Scope. History. History. Incretins. Incretin-based Therapy and DPP-4 Inhibitors

Upregulation of Intestinal Glucose Transporters after Roux-en-Y Gastric Bypass to Prevent Carbohydrate Malabsorption

LESSON 3.3 WORKBOOK. How do we decide when and how much to eat?

Intestinal Hypertrophy and Increased Glucose Transporter Expression after Gastric Bypass. Senior Thesis. Presented to

Revision For Weight Regain

Initially more rapid small intestinal glucose delivery increases plasma. insulin, GIP and GLP-1, but does not improve overall glycemia in

Gastrointestinal Hormones and Bariatric Surgery-induced Weight Loss

Weight Regulation after Bariatric Surgery

How the gut talks to the brain:

Obesity Management in Patients with Diabetes Jamy D. Ard, MD Sunday, February 11, :15 a.m. 11:00 a.m.

BARIATRIC SURGERY. Weight Loss Surgery. A variety of surgical procedures to reduce weight performed on people who have obesity. Therapy Male & Female

Diabetes Risk Assessment and Treatment

MULTI-CENTER, PROSPECTIVE, CONTROLLED TRIAL OF THE DUODENAL JEJUNAL BYPASS LINER FOR THE TREATMENT OF TYPE 2 DIABETES IN OBESE PATIENTS

CME Post Test. D. Treatment with insulin E. Age older than 55 years

Type 2 DM in Adolescents: Use of GLP-1 RA. Objectives. Scope of Problem: Obesity. Background. Pathophysiology of T2DM

Bariatric surgery as a model for obesity research. Nick Finer BSc, FRCP, FAfN University College London UK

GLP-1 Receptor Agonists and SGLT-2 Inhibitors. Debbie Hicks

Postprandial Nutrient Handling and Gastrointestinal Hormone Secretion After Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy

Effect of Bariatric Surgery on Cardio-Metabolic Outcomes

Original paper Videosurgery

Therapeutic strategy to reduce Glucagon secretion

A Bariatric Patient in my Waiting Room: Choosing the Right Patient for the Right Operation: Bariatric Surgery Indications

Sue Cummings, MS, RD

Bariatric Surgery. Options & Outcomes

Formulation and development of foods for weight management. Paola Vitaglione

10/27/2016. Processing in the Large Intestine. The colon of the large intestine is connected to the small intestine

Abstract. KEY WORDS: obesity, type 2 diabetes, metabolic surgery, laparoscopic sleeve gastrectomy and bariatric surgery. Introduction.

Oat beta glucan: Multiple roles in the gut. A.R. Mackie, B.H. Bajka, B. Kirkhus

Understanding the Biology of Weight and Weight Regain to Assist those Challenged with Obesity

4. Mechanisms Mediating Weight Loss and Diabetes Remission After Bariatric/ Metabolic Surgery

Bariatric Surgery. Policy Number: Last Review: 12/2018 Origination: 10/1988 Next Review: 12/2019

Chapter 12. Ingestive Behavior

GLP-1. GLP-1 is produced by the L-cells of the gut after food intake in two biologically active forms It is rapidly degraded by DPP-4.

Subcutaneous exendin (9-39) effectively treats post-bariatric hypoglycemia

Sitagliptin: first DPP-4 inhibitor to treat type 2 diabetes Steve Chaplin MSc, MRPharmS and Andrew Krentz MD, FRCP

* Assit. prof., *** Prof. & Head of deptt., Deptt. of Surgery, MGIMS ** Asstt prof Deptt. of Medicine. REVIEW ARTICLE

IDF Regions and global projections of the number of people with diabetes (20-79 years), 2013 and Diabetes Atlas -sixth Edition: IDF 2013

Non-nutritive sweeteners: no class effect on the glycemic or appetite responses to ingested glucose

Effects of ingestion routes on hormonal and metabolic profiles in gastric-bypassed humans

6/23/2011. Bariatric Surgery: What the Primary Care Provider Should Know. Case Presentation: Rachelle

Diabetes control and lessened cerebral cardiovascular risks after gastric bypass surgery in Asian Taiwanese with a body mass index <35 kg/m2

Motility Conference Ghrelin

Gastroparesis: Diagnosis and Management

Transcription:

Appetite, Glycemia and Entero-Insular Hormone Responses Differ Between Oral, Gastric-Remnant and Duodenal Administration of a Mixed Meal Test After Roux-en-Y Gastric Bypass

June 2018

How a surgical complication provided an experimental model. Baseline 37 years old male patient, non-diabetic RYGB for severe obesity (BMI 43 kg/m 2 ) in a peripheral hospital 4 months Reoperation for internal hernia, complicated by intestinal perforation Postoperative septic shock -> transfer our tertiary bariatric referral center Upon arrival at USZ: Laparotomy to repair intestinal perforations Insertion of a double-lumen percutaneous gastrostomy to the remnant stomach - gastric decompression - post-pyloric enteral nutrition (tip of line: D3) 6 months -> weight stabilized (BMI = 35 kg/m 2 ), good general condition

Bariatric surgery s effect on Type 2 diabetes mellitus Rubino. Diab Care. 2016

Bariatric surgery s effect on Type 2 diabetes mellitus Rubino. Diab Care. 2016

GLP-1 effects in humans GLP-1 secreted upon the ingestion of food Half-life = 2-3 min 5.Brain: Promotes satiety and reduces appetite 4,5 2.α-cell: Suppresses postprandial glucagon secretion 1 1. -cell: Enhances glucosedependent insulin secretion in the pancreas = INCRETIN 1 3.Liver: reduces hepatic glucose output 2 4.Stomach: slows the rate of gastric emptying 3 Adapted from 1 Nauck MA, et al. Diabetologia 1993;36:741 744; 2 Larsson H, et al. Acta Physiol Scand 1997;160:413 422; 3 Nauck MA, et al. Diabetologia 1996;39:1546 1553; 4 Flint A, et al. J Clin Invest 1998;101:515 520; 5 Zander et al. Lancet 2002;359:824 830.

Rubino. Ann Surg. 2002 Glycemic control after RYGB: Mechanism? (PYY, GIP) FOREGUT HINDGUT

Post-bariatric gut hormone response in humans Switching on/off the RYGB ClinicalTrials.gov Identifier: NCT01025999 Pournaras D, Bueter M, Surg Obes Rel Dis. 2012 Dirksen C, Diab Care. 2010

Systemic bias in study design Speed of food arrival into the intestines might matter Ma. Diabet Med. 2012

Our hypothesis Nutrients delivered into the duodenum lead to a. comparable changes in Gut hormones, Glucose metabolism & Appetite as orally b. but different to the gastrostomy

New concept Design Resource 200 ml test meal in 4min Baseline to 120 min blood tests 2x each route Gastric emptying assessment Gastrografin with X-ray 30min later Ethical approval Cantonal Ethics Committee of Zürich BASEC-Nr. Req-2017-0616

Gut hormone response GLP-1 PYY Hypothesis: Correct! Duodenal = Oral

Gut hormone response GIP

Glucose metabolism Glucose Insulin Other factors may play a role

Appetite (Visual analogue scale) Hunger Fullness

Gastric emptying at 20 minutes

Main limitation n = 1 (ethical obstacles to reproduce the model)

Discussion

1. Adaptation of Roux-limb «Enteroplasticity» GLP1-cell (L) hyperplasia after RYGB GLUT1 upregulation Cavin. Gastroenterology. 2016 Hansen,Bueter. Plos One. 2013

2. Fast gastric-pouch emptying Gastric pouch emptying rate of glucose drink extremely rapid -> T 1/2 of 3 min (Scintigraphic measurement) Supraphysiologic intestinal nutrient delivery of 107 kcal/min = x 25 increase Nguyen. Obesity. 2014 Salehi. Diabetes Obes Metab. 2017

Take home message Post-RYGB physiology seems to be more complex than initially thought Forgut/hindgut theory needs to be challenged in future trials For example, by testing the role of intestinal food arrival velocity Roux-limb adaptation

Marco Bueter, MD, PhD Rolf Graf, PhD Robert E. Steinert, PhD Felix Beuschlein, MD, PhD Hanna Hosa, MD Pierre-Alain Clavien, MD, PhD Thomas Lutz, Dr. med. vet. (physiology of eating) David E. Cummings, MD, PhD (diabetologist) Pelagia Kakka (line art figure)